Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri Skerget

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Systems Biology in Reproductive Medicine|July 14, 2012
Proteomic discovery of diverse immunity molecules in mammalian spermatozoaSteve Dorus, Sheri Skerget, Timothy L Karr
Plos One|November 12, 2015
Sperm Proteome Maturation in the Mouse EpididymisSheri Skerget, Matthew A Rosenow, Konstantinos Petritis, et al.
Journal of Proteomics|October 27, 2018
Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteomeMelissah Rowe, Sheri Skerget, Matthew A Rosenow, et al.
Leukemia Research|August 23, 2021
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatmentKrisstina Gowin, Sheri Skerget, Jonathan J Keats, et al.
Molecular & Cellular Proteomics : MCP|July 3, 2013
The Rhesus macaque (Macaca mulatta) sperm proteomeSheri Skerget, Matthew Rosenow, Ashoka Polpitiya, et al.
Blood|September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myelomaHolly Lee, Michael Durante, Sheri Skerget, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2024
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple MyelomaChristie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, et al.
Cancer Medicine|October 2, 2025
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple MyelomaNiels W C J van de Donk, Ajai Chari, Thomas Martin, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Haematologica|June 11, 2026
Longitudinal mechanisms of response, resistance and relapse to teclistamab in multiple myeloma: results from MajesTEC-1Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Systems Biology in Reproductive Medicine|July 14, 2012
Proteomic discovery of diverse immunity molecules in mammalian spermatozoaSteve Dorus, Sheri Skerget, Timothy L Karr
Plos One|November 12, 2015
Sperm Proteome Maturation in the Mouse EpididymisSheri Skerget, Matthew A Rosenow, Konstantinos Petritis, et al.
Journal of Proteomics|October 27, 2018
Identification and characterization of the zebra finch (Taeniopygia guttata) sperm proteomeMelissah Rowe, Sheri Skerget, Matthew A Rosenow, et al.
Leukemia Research|August 23, 2021
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatmentKrisstina Gowin, Sheri Skerget, Jonathan J Keats, et al.
Molecular & Cellular Proteomics : MCP|July 3, 2013
The Rhesus macaque (Macaca mulatta) sperm proteomeSheri Skerget, Matthew Rosenow, Ashoka Polpitiya, et al.
Blood|September 25, 2024
Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in multiple myelomaHolly Lee, Michael Durante, Sheri Skerget, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 30, 2024
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple MyelomaChristie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans, et al.
Cancer Medicine|October 2, 2025
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple MyelomaNiels W C J van de Donk, Ajai Chari, Thomas Martin, et al.
Blood Advances|August 27, 2025
Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk, et al.
Haematologica|June 11, 2026
Longitudinal mechanisms of response, resistance and relapse to teclistamab in multiple myeloma: results from MajesTEC-1Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, et al.
Pageof 2